Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto (Sacubitril/Valsartan) in Heart Failure
Clinical trial NCT03387163 · COMPLETED
Trial details
- NCT number
- NCT03387163
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-02-09
- Primary completion
- 2019-06-21
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.